Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become ...

Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Operator can use a web browser to carry out tasks – such as booking services or online shops – autonomously once instructed by the user.

OpenAI has demoed the AI agent browsing the web just like a human would, with the ability to interact with websites and ...

In a moment of buzzy optimism known as “Web 2.0,” Julia Hartz started Eventbrite with Kevin Hartz, then her fiancé and soon her husband, and Renaud Visage. That was 2006. Fast forward nearly two ...

OpenAI CEO Sam Altman envisions a future where artificial intelligence (AI) surpasses human intelligence and becomes a ...

OpenAI has created a ChatGPT model called GPT-4b micro for Retro Biosciences, a longevity research company - here's what it ...

Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite ...

OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...